# Ethics, Legal, and Privacy Guidelines

## ⚠️ CRITICAL WARNINGS

1. **NOT FOR CLINICAL USE**: This software is for **research purposes only**. It does NOT replace clinical decision-making, diagnostic procedures, or medical advice.

2. **IRB/Ethics Approval Required**: Using real patient data requires Institutional Review Board (IRB) or Ethics Committee approval. Do NOT proceed without proper authorization.

3. **No PHI in Public Repositories**: Protected Health Information (PHI) must NEVER be uploaded to GitHub or any public repository.

## Ethical Principles

### 1. Informed Consent

- All participants must provide **informed consent** before data collection
- Consent forms must clearly state:
  - Purpose of research
  - Data collection methods
  - Data storage and sharing policies
  - Right to withdraw
  - Biobanking and future use options
  - Potential risks and benefits

### 2. Data Anonymization

**Required anonymization steps**:

- Remove or pseudonymize:
  - Patient names
  - Medical record numbers
  - Social security numbers
  - Dates of birth (convert to age ranges or "days since" format)
  - Exact dates (convert to relative dates)
  - Geographic identifiers (if small populations)
  - Any other identifiers

- Use pseudonymized patient IDs (e.g., `P1234`)
- Store mapping between pseudonyms and real IDs separately (encrypted, access-controlled)

### 3. Data Storage and Security

- Real patient data must be stored on **secure, access-controlled servers**
- Encryption at rest and in transit
- Regular security audits
- Access logs maintained
- Data retention policies clearly defined

### 4. Data Sharing

**Public repositories (GitHub, etc.)**:
- ✅ Synthetic data (generated, not from real patients)
- ✅ Code and analysis pipelines
- ✅ Documentation
- ❌ Real patient data (even if "anonymized")
- ❌ Any data that could be re-identified

**Real data sharing**:
- Requires **Data Transfer Agreement (DTA)**
- Requires recipient IRB approval
- Requires explicit consent from participants
- Must comply with local regulations (GDPR, HIPAA, etc.)

### 5. Fairness and Bias

- Evaluate model performance across demographic subgroups:
  - Sex/gender
  - Age groups
  - Ethnicity/race
  - Socioeconomic status
- Report any performance disparities
- Mitigate bias when possible
- Acknowledge limitations in publications

### 6. Transparency and Reproducibility

- Document all preprocessing steps
- Version control for models and data
- Maintain audit trails (who/when/why)
- Report limitations and potential biases
- Make code and methods publicly available (when possible)

## Legal Compliance

### Regulations to Consider

1. **HIPAA (US)**: Health Insurance Portability and Accountability Act
   - Protects PHI
   - Requires Business Associate Agreements for data sharing
   - Requires breach notification

2. **GDPR (EU)**: General Data Protection Regulation
   - Requires explicit consent
   - Right to access, rectification, erasure
   - Data minimization principles
   - Privacy by design

3. **Local Regulations**: Comply with all applicable local laws

### Required Documentation

1. **IRB Protocol**: Must include:
   - Study objectives
   - Data collection procedures
   - Sample storage and handling
   - Analysis plan
   - Data sharing plan
   - Consent procedures

2. **Data Use Agreement (DUA)**: For sharing data between institutions

3. **Material Transfer Agreement (MTA)**: For sharing samples

## Data Collection Protocol

### Sample Collection

- Standardized collection protocol:
  - Time of collection (fasting status)
  - Storage conditions (-80°C recommended)
  - No anticoagulants
  - Chain of custody documentation

### Quality Control

- Internal standards
- Blank samples
- Pooled QC samples
- Batch randomization
- Instrument calibration records

### Labeling

- Use pseudonymized IDs only
- No PHI on sample labels
- Maintain secure mapping file separately

## Model Development Ethics

### Training Data

- Ensure representative sample
- Document inclusion/exclusion criteria
- Report missing data patterns
- Validate across subgroups

### Model Validation

- Use independent test sets
- Cross-validation with proper stratification
- External validation when possible
- Report confidence intervals

### Clinical Translation

- **This is a research prototype**
- Requires extensive validation before clinical use
- Regulatory approval may be required (FDA, CE marking, etc.)
- Clinical trials may be necessary

## Publication and Dissemination

### What Can Be Shared

- ✅ Methods and algorithms
- ✅ Synthetic data
- ✅ Aggregate statistics (properly anonymized)
- ✅ Model architectures
- ✅ Performance metrics (with limitations)

### What Cannot Be Shared

- ❌ Individual-level patient data
- ❌ Data that could be re-identified
- ❌ PHI in any form
- ❌ Exact dates, locations, or other identifiers

### Required Statements in Publications

1. "This research was approved by [Institution] IRB (Protocol #XXX)"
2. "All participants provided informed consent"
3. "This model is for research purposes only and not for clinical use"
4. "Data sharing is restricted due to privacy concerns"
5. Limitations and potential biases

## Incident Response

### Data Breach

- Immediate notification to:
  - IRB
  - Data protection officer
  - Affected participants (if required)
  - Regulatory authorities (if required)
- Document incident
- Implement corrective measures

### Re-identification Risk

- Regular risk assessments
- Monitor for potential re-identification
- Update anonymization procedures as needed

## Contact and Reporting

- **IRB Contact**: [Your Institution's IRB Office]
- **Data Protection Officer**: [If applicable]
- **Principal Investigator**: [Contact Information]

## Version History

- **Version 1.0**: Initial ethics guidelines
- Last updated: [Date]

## Acknowledgments

These guidelines are based on:
- Declaration of Helsinki
- CIOMS Guidelines
- Local IRB requirements
- GDPR and HIPAA regulations

---

**Remember**: When in doubt, consult your IRB, legal counsel, or data protection officer. It is better to be overly cautious than to risk patient privacy or violate regulations.
